The moves took US stocks into bear market territory, leaving investors asking the question: “How low can this go?” For Emma ...

ResMed Inc. closed 19.96% below its 52-week high of $263.05, which the company achieved on January 30th.

ResMed shares have been caught up in the recent market volatility. Has this created a buying window for ResMed shares?

Macquarie notes that ResMed manufactures ~40% of its products in the U.S., shielding it from some of the trade-related cost ...

From Regal’s Phil King, who says stocks are nearing their bottom, to Airlie’s Emma Fisher, buying US-exposed equities, here ...

Shares of ResMed Inc. RMD slipped 3.97% to $204.54 Tuesday, on what proved to be an all-around poor trading session for the ...

In a welcome move, ResMed saw its Relative Strength Rating rise from 65 to 78 on Tuesday. Please watch the video at Investors ...

ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Professional networking site LinkedIn has put together its annual list of Australia's best workplaces for career growth ...

SAN DIEGO – Resmed has announced that its home sleep apnea test, NightOwl, is now available across the U.S.

Post Liberation Day, life science companies are clarifying the likely impact of Trump's tariffs – and the news is largely positive.

StockNews.com downgraded shares of ResMed (NYSE:RMD – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday morning. A number of other equities research ...